{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:01:12Z","timestamp":1785787272170,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH","award":["NS045962"],"award-info":[{"award-number":["NS045962"]}]},{"name":"NIH","award":["NS073994"],"award-info":[{"award-number":["NS073994"]}]},{"name":"ORIP\/OD","award":["P51OD011132"],"award-info":[{"award-number":["P51OD011132"]}]},{"name":"Pfizer, Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jneumeth.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,2,16]],"date-time":"2013-02-16T02:00:25Z","timestamp":1360980025000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of adverse effects of neurotropic drugs in monkeys with the \u201cDrug Effects on the Nervous System\u201d (DENS) scale"],"prefix":"10.1016","volume":"215","author":[{"given":"Subramaniam","family":"Uthayathas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Menniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2013.02.004_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF02245613","article-title":"Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys","volume":"124","author":"Casey","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0010","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/BF02245007","article-title":"Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman-primates","volume":"112","author":"Casey","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1192\/bjp.166.5.650","article-title":"A self-rating scale for measuring neuroleptic side-effects\u2014validation in a group of schizophrenic-patients","volume":"166","author":"Day","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0020","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0025","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1124\/dmd.112.046391","article-title":"An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations","volume":"40","author":"Doran","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/schbul\/sbs073","article-title":"Psychiatry, the pharmaceutical industry, and the road to better therapeutics","volume":"38","author":"Fibiger","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1348\/000711006X126600","article-title":"Computing inter-rater reliability and its variance in the presence of high agreement","volume":"61","author":"Gwet","year":"2008","journal-title":"Br J Math Stat Psychol"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003142","article-title":"Revolution stalled","volume":"4","author":"Hyman","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0050","series-title":"Institute of Laboratory Animal Resources-Commission on Life Sciences NRC, editor","article-title":"Guide for the care and use of laboratory animals","author":"ILAR","year":"1996"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.archger.2004.05.004","article-title":"Correlation of Mini-Mental-State-Examination (MMSE), Syndrom-Kurztest (SKT) and Clock test (CT) scores in patients with cognitive impairment assessed by means of multiple regression and response surface analysis","volume":"40","author":"Koch","year":"2005","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(02)02957-6","article-title":"Comparative behavioural effects of typical and atypical antipsychotic drugs in rhesus monkey","volume":"462","author":"Kumar","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1460-9568.2009.06718.x","article-title":"Antagonism of serotonergic 5-HT2A\/2C receptors: mutual improvement of sleep, cognition and mood?","volume":"29","author":"Landolt","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The Uku side-effect rating-scale\u2014a new comprehensive rating-scale for psychotropic-drugs and a cross-sectional study of side-effects in neuroleptic-treated patients\u2014preface","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0080","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0893-133X(01)00251-2","article-title":"Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride","volume":"25","author":"Mukherjee","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0085","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1176\/ajp.156.6.869","article-title":"Suggested minimal effective dose of risperidone based on PET-measured D-2 and 5-HT2A receptor occupancy in schizophrenic patients","volume":"156","author":"Nyberg","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ana.20279","article-title":"Prolongation of levodopa responses by glycine(B) antagonists in parkinsonian primates","volume":"56","author":"Papa","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys","volume":"39","author":"Papa","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0105","first-page":"55","article-title":"Defining neuropharmacokinetic parameters in CNS drug discovery to determine cross-species pharmacologic exposure\u2013response relationships","volume":"45","author":"Shaffer","year":"2010","journal-title":"Annu Rep Med Chem"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0110","first-page":"137","article-title":"Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics","volume":"25","author":"Stip","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00213-004-2114-1","article-title":"Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys","volume":"179","author":"Terry","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jneumeth.2013.02.004_bib0120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/dmd.106.013953","article-title":"Central nervous system pharmacokinetics of the mdr1 p-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures","volume":"35","author":"Venkatakrishnan","year":"2007","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027013000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027013000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:30:46Z","timestamp":1759019446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027013000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0165027013000708"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2013.02.004","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of adverse effects of neurotropic drugs in monkeys with the \u201cDrug Effects on the Nervous System\u201d (DENS) scale","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2013.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}